Skip to main content
. 2020 Apr 30;12(4):e7898. doi: 10.7759/cureus.7898

Table 1. Medical management of eosinophilic esophagitis.

AGENT ROUTE OF ADMINISTRATION EFFECTS ADVERSE REACTIONS
Proton Pump Inhibitors Oral 1) Decreased acid secretion, 2) Anti-inflammatory Headache, nausea, diarrhea
Topical Glucocorticoids Oral 1) Decreased eosinophil counts Abdominal pain, oral thrush, hoarseness of voice
Fluticasone propionate Metered-dose inhaler without a spacer 1) Relief of dysphagia, 2) Decreased inflammation of the esophagus Oral thrush, cataracts, adrenal suppression and relapse
Budesonide Nebulizer 1) Relief of dysphagia, 2) Decreased inflammation of the esophagus, 3) Decreased eosinophil counts. Oral thrush and relapse
Ciclesonide Oral Decreased eosinophil counts in the proximal and distal esophagus as shown in histopathology. Unpleasant taste, dryness, and burning sensation in the mouth.